Lipids: Update on Diagnosis and Management of Dyslipidemia, An Issue of Endocrinology and Metabolism Clinics of North America

Timely, relevant discussions on diagnosis and management of dyslipidemia

Connie B. Newman (Edited by), Alan Chait (Edited by)

9780323986953, Elsevier Health Sciences

Hardback, published 18 August 2022

240 pages
28 x 19 x 2.1 cm, 0.57 kg

In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Connie B. Newman and Alan Chait bring their considerable expertise to the topic of Lipids: Update on Diagnosis and Management of Dyslipidemia. When untreated, dyslipidemia may have serious comorbidities; in this issue, top experts cover the evaluation and management of LDL cholesterol and high triglicerides in adults and children, providing practical information that will help physicians and other health care professionals treat their patients and improve outcomes.

• Contains 13 practice-oriented topics including lipid and lipoprotein metabolism; measurement of lipids and advanced lipid testing; assessment of CVD risk; inherited forms of hypercholesterolemia; new and emerging therapies for dyslipidemia; and more. 

• Provides in-depth clinical reviews on diagnosis and management of dyslipidemia, offering actionable insights for clinical practice. 

• Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

Lipid and Lipoprotein Metabolism
Lipoprotein Assessment in the twenty-first Century
Assessment of Cardiovascular Disease Risk: A 2022 Update
The Inherited Hypercholesterolemias
Hypertriglyceridemia
High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?
Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents
Management of Dyslipidemia in Endocrine Diseases
Dyslipidemia in Diabetes: When and How to Treat?
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease
New and Emerging Therapies for Dyslipidemia
Safety of Statins and Nonstatins for Treatment of Dyslipidemia
LDL Cholesterol—How Low Can We Go?

Subject Areas: Metabolism [MFGM]